High Mortality Among Human Immunodeficiency Virus (HIV)-Infected Individuals Before Accessing or Linking to HIV Care: A Missing Outcome in the Cascade of Care?

Open Forum Infectious Diseases
Hartmut B KrentzM John Gill

Abstract

The "cascade of care" displays the proportion of individuals who are infected with human immunodeficiency virus (HIV), diagnosed, linked, retained, on antiretroviral treatment, and HIV suppressed. We examined the implications of including death in the use of this cascade for program and public health performance metrics. Individuals newly diagnosed with HIV and living in Calgary between 2006 and 2013 were included. Through linkage with Public Health and death registries, the deaths (ie, all-cause mortality) and their distribution within the cascade were determined. Mortality rates are reported per 100 person-years. Estimated new HIV infections were 680 (543 confirmed and 137 unknown cases). Forty-three individuals, after diagnosis, were never referred for HIV care. Despite referral(s), 88 individuals (18%) never attended the clinic for HIV care. Of individuals retained in care, 87% received antiretroviral therapy and 76% achieved viral suppression. Thirty-six deaths were reported (mortality rate, 1.50/100 person-years). One diagnosis was made posthumously. Deaths (20 of 35; 57%) occurred for individuals linked but not retained in care (6.93/100 person-years), and 70% were HIV-related. Mortality rate for patients in care was 0.7...Continue Reading

References

Aug 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Frank J PalellaUNKNOWN HIV Outpatient Study Investigators
Aug 1, 2007·AIDS Patient Care and STDs·Carol TobiasMoses B Pounds
Sep 28, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Enrico GirardiAntonella D'Arminio Monforte
Jun 11, 2008·Archives of Internal Medicine·Lucia V TorianThomas R Frieden
Dec 6, 2008·AIDS Patient Care and STDs·Kimberly B UlettMichael J Mugavero
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael J MugaveroJeroan J Allison
Apr 3, 2009·The New England Journal of Medicine·Mari M KitahataUNKNOWN NA-ACCORD Investigators
Apr 29, 2009·PLoS Medicine·Martin W G BrinkhofUNKNOWN International Epidemiological Databases to Evaluate AIDS (IeDEA)
Jul 28, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·N KumarasamySuniti Solomon
Sep 23, 2009·AIDS·UNKNOWN HIV-CAUSAL CollaborationMiguel A Hernán
Feb 24, 2010·AIDS·Jacqueline NeuhausUNKNOWN INSIGHT SMART and ESPRIT study groups
Apr 13, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Antiretroviral Therapy Cohort Collaboration
Apr 27, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keri N AlthoffRichard D Moore
Sep 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Milo A PuhanUNKNOWN Ocular Complications of AIDS Research Group
Sep 23, 2010·AIDS Patient Care and STDs·Michael J MugaveroThomas P Giordano
Nov 13, 2010·International Journal of Women's Health·Arif AlibhaiTom Rubaale
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward M GardnerWilliam J Burman
Dec 6, 2012·Current Opinion in HIV and AIDS·Peter H Kilmarx, Tsitsi Mutasa-Apollo
Mar 2, 2013·Public Health Reports·Jeanne BertolliUNKNOWN Never in Care Pilot Project Team
Jun 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael J MugaveroMelanie A Thompson
Oct 1, 2013·The Lancet Infectious Diseases·Bohdan NosykUNKNOWN STOP HIV/AIDS Study Group
Oct 30, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael G EberhartKathleen A Brady

❮ Previous
Next ❯

Citations

Nov 7, 2015·Current Opinion in HIV and AIDS·Noah HaberTill Bärnighausen
Mar 1, 2018·HIV Medicine·S CroxfordUNKNOWN OptTEST by HIV in Europe
Dec 6, 2018·Cadernos de saúde pública·Ingridt Hildegard VoglerEdna Maria Vissoci Reiche

❮ Previous
Next ❯

Software Mentioned

CoDe

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.